Junshi Biosciences Announces Acceptance of Supplemental New Drug Application for Toripalimab as First-Line Treatment of Unresectable/Metastatic Melanoma
Bedford Metals Obtains Satellite Survey Results on the Sheppard Lake Uranium Project, Northern Saskatchewan
Sandoz receives FDA approval for Enzeevu™ (aflibercept-abzv), further strengthening US biosimilar position
HYCU® Named a Visionary in the 2024 Gartner® Magic Quadrant™ for Enterprise Backup and Recovery Software Solutions Notified -
AXI SELECT TRADERS CHIA SẺ KINH NGHIỆM TRONG CHƯƠNG TRÌNH PHÂN BỔ VỐN CỦA AXI TRONG LOẠT PODCAST MỚI AXI SELECT TALKS
Recursion and Exscientia Enter Definitive Agreement to Create a Global Technology-Enabled Drug Discovery Leader with End-to-End Capabilities
Axi Select Traders Share Their Experience So Far on Axi’s Capital Allocation Program in New Podcast Series Axi Select Talks
